Generated Narrative: EvidenceVariable 583782 version: 2; Last updated: 2026-07-27 13:49:52+0000 Profile: VariableDefinition ArtifactPublicationStatus: Active url: https://fevir.net/resources/EvidenceVariable/583782 identifier: FEvIR Object Identifier/583782, FEvIR Linking Identifier/NCT05327010-otherOutcome-6 name: Assess_emergent_resistant_mutations_NCT05327010 title: Assess emergent resistant mutations (NCT05327010) citeAs: Assess emergent resistant mutations (NCT05327010) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 583782. Revised 2026-07-27. Available at: https://fevir.net/resources/EvidenceVariable/583782. Computable resource at: https://fevir.net/resources/EvidenceVariable/583782#json. status: Active author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: publisher: Computable Publishing LLC contact: support@computablepublishing.com description: Includes BRCA reversion. copyright: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse). Definitions - Concept * Assess emergent resistant mutations Includes BRCA reversion. handling: Evidence variable handling not specified Timings - Text * At progression
Assess emergent resistant mutations (NCT05327010)
Assess emergent resistant mutations (NCT05327010) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 583782. Revised 2026-07-27. Available at: https://fevir.net/resources/EvidenceVariable/583782. Computable resource at: https://fevir.net/resources/EvidenceVariable/583782#json.
Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
Assess emergent resistant mutations Includes BRCA reversion.
Evidence variable handling not specified